Can Financial Engineering Cure Cancer? – Webinar recording

In this EVX-BCS webinar, Professor Andrew Lo from the MIT Sloan School of Management will explain how the tools of financial engineering—portfolio theory, securitization, credit default swaps, and other commonly used financial techniques—can be used to reduce the risk and increase the attractiveness of biomedical innovation so as bring new therapies to patients faster.

The BCS Startup Series – Funding schemes for Innovation Enterprises in Singapore: Post Event Write-up

In this instalment of the BCS Startup Series on funding schemes, we invite managers and program directors from National Health Innovation Centre (NHIC) Singapore and SME Centre @ Singapore Indian Chamber of Commerce and Industry (SME Centre@SICCI), an initiative of Enterprise Singapore, to share with us about the capability assistance programmes and other programs under the same initiative (i.e. Startup SG programs), that businesses can explore and some useful information about the application process.

Duke-NUS Bio-Entrepreneur Series – Spinning out a cancer immunotherapy startup – The Story of PairX Bio: Post-Event Write-Up

In this webinar, we will feature the story of PairX Bio (“PairX”), a new Singapore-based Biotech Company in cancer immunotherapy and latest spin-off from Duke-NUS AMC. The panel featuring Dr Raymond Lee, Scientific Co-founder of PairX; Mr XQ Lin, an investor in PairX; and Ms Cheryl McCaffrey, Director of Duke-NUS’ CTed, will share their insights on the opportunities and challenges of starting a biotech company.

Legal 101 for Biotech

Dr. Lila Hope of Cooley LLP discussed a biotech company’s timeline in relation to product development and summarised the different third party agreements a company might contract along the length of this timeline. These agreements could range from research collaborations, sponsored research agreements, technology licenses, engagement of service providers, MTAs to corporate partnerships.